TC BioPharm Announces Exercise Of Warrants For £3.1 Million Gross Proceeds
TC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ:TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced the entry into a